Latest Articles

Publication Date
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com Canada

Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com Canada

Published: Jan. 23, 2026, 10:24 p.m.
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com Australia

Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com Australia

Published: Jan. 23, 2026, 3:48 p.m.
Ibuprofen may decrease cancer risk - Female First

Ibuprofen may decrease cancer risk Female First

Published: Jan. 23, 2026, 3:16 p.m.
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com

Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com

Published: Jan. 23, 2026, 2:07 p.m.
Acrivon to present ACR-368 endometrial cancer data at ESGO congress - Investing.com UK

Acrivon to present ACR-368 endometrial cancer data at ESGO congress Investing.com UK

Published: Jan. 23, 2026, 1:18 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - Targeted Oncology

Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer Targeted Oncology

Published: Jan. 22, 2026, 4:02 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - targetedonc.com

Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer targetedonc.com

Published: Jan. 22, 2026, 4:02 p.m.
Novel Vaccine Combo Shows Responses in Recurrent Epithelial Ovarian Cancer - CancerNetwork

Novel Vaccine Combo Shows Responses in Recurrent Epithelial Ovarian Cancer CancerNetwork

Published: Jan. 21, 2026, 4:57 p.m.
Teacher shares her incredible fight against endometrial adenocarcinoma, a cancer of the reproductive syst - Times of India

Teacher shares her incredible fight against endometrial adenocarcinoma, a cancer of the reproductive syst Times of India

Published: Jan. 21, 2026, 3:17 p.m.
Management of Suspected Stage IVA Endometrial Cancer With Rectosigmoid Involvement Using Neoadjuvant Chemotherapy and Interval Surgery - Cureus

Management of Suspected Stage IVA Endometrial Cancer With Rectosigmoid Involvement Using Neoadjuvant Chemotherapy and Interval Surgery Cureus

Published: Jan. 21, 2026, 1:51 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!